Evidence map›Paper›PMID 40460345›Full record

ArticlePLoS pathogens2025

Role of the CTCF binding site in Human T-Cell Leukemia Virus-1 pathogenesis.

Ancy Joseph, Xiaogang Cheng, John Harding, Jacob Al-Saleem, Patrick Green, Malachi Griffith, Deborah Veis, Daniel A Rauch, Lee Ratner

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Ancy JosephDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Xiaogang ChengDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
John HardingDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Jacob Al-SaleemCenter for Retrovirus Research and Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, United States of America.
Patrick GreenCenter for Retrovirus Research and Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, United States of America.
Malachi GriffithDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Deborah VeisDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Daniel A RauchDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Lee RatnerDepartment of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.ORCID 0000-0003-2744-7294

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI David G DeNardo · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Role of Inflammation in Tax-mediated TumorigenesisP01CA100730 · NCI · WASHINGTON UNIVERSITY · PI Lee Ratner · 2003 to 2026
$44.8M
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia LymphomaR01CA258359 · NCI · WASHINGTON UNIVERSITY · PI Lee Ratner, Daniel Arthur Rauch · 2022 to 2026
$1.8M
Interaction of HTLV-1 Tax & Hbz in TransformationR21CA252869 · NCI · WASHINGTON UNIVERSITY · PI RATNER, LEE, RAUCH, DANIEL ARTHUR · 2021 to 2022
$401k
NCATS NIH HHS UL1 TR002345NCI NIH HHS P01 CA100730NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA258359NCI NIH HHS R21 CA252869
6 · The paper itself

Abstract

During HTLV-1 infection, the virus integrates into the host cell genome as a provirus with a single CCCTC binding protein (CTCF) binding site (vCTCF-BS), which acts as an insulator between transcriptionally active and inactive regions. Previous studies have shown that the vCTCF-BS is important for maintenance of chromatin structure, regulation of viral expression, and DNA and histone methylation. Here, we show that the vCTCF-BS also regulates viral infection and pathogenesis in vivo in a humanized (Hu) mouse model of adult T-cell leukemia/lymphoma. Three cell lines were used to initiate infection of the Hu-mice, i) HTLV-1-WT which carries an intact HTLV-1 provirus genome, ii) HTLV-1-CTCF, which contains a provirus with a mutated vCTCF-BS which abolishes CTCF binding, and a stop codon immediately upstream of the mutated vCTCF-BS which deletes the last 23 amino acids of the p12 gene, and iii) HTLV-1-p12stop that contains the intact vCTCF-BS, but retains the same stop codon in p12 as in the HTLV-1-CTCF cell line. Hu-mice were infected with mitomycin-treated or irradiated HTLV-1 producing cell lines. There was a delay in pathogenicity when Hu-mice were infected with the HTLV-1-CTCF virus compared to mice infected with either HTLV-1-p12 stop or HTLV-1-WT virus. Proviral load (PVL), spleen weights, and CD4 T cell counts were significantly lower in HTLV-1-CTCF infected mice compared to HTLV-1-p12stop infected mice. Furthermore, we found a direct correlation between the PVL in peripheral blood and death of HTLV-1-CTCF infected mice. In cell lines, we found that the vCTCF-BS regulates Tax expression in a time-dependent manner. The scRNAseq analysis of splenocytes from infected mice suggests that the vCTCF-BS plays an important role in activation and expansion of T lymphocytes in vivo. Overall, these findings indicate that the vCTCF-BS regulates Tax expression, proviral load, and HTLV pathogenicity in vivo.

Indexed as

CCCTC-Binding FactorHTLV-I InfectionsHuman T-lymphotropic virus 1Leukemia-Lymphoma, Adult T-CellAnimalsBinding SitesHumansMiceProvirusesCCCTC-Binding FactorCTCF protein, human

Identifiers

PMID40460345
PMCPMC12165413

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.